DKL Dr.Kalebi Labs, DKL Drive Kalebi Labs, Real Towers Annex, Nairobi (2026)

14/07/2026

𝗪𝗲𝗹𝗰𝗼𝗺𝗶𝗻𝗴 𝗕𝗮𝗰𝗸 𝗗𝗿. 𝗔𝗻𝗱𝗿𝗲𝘄 𝗢𝗱𝗵𝗶𝗮𝗺𝗯𝗼: 𝗟𝗲𝗮𝗱𝗶𝗻𝗴 𝗯𝘆 𝗘𝘅𝗮𝗺𝗽𝗹𝗲 𝗶𝗻 𝗣𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝘃𝗲 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲

Dr. Kalebi Labs (DKL) was delighted to once again welcome Dr. Andrew Odhiambo, Consultant Medical Oncologist, who returned for his annual comprehensive medical check-up, having entrusted us with his health assessment last year as well.

His continued commitment to routine health screening is a powerful reminder that preventive healthcare is one of the most important investments anyone can make. Regular medical check-ups enable early detection of potential health conditions, facilitate timely intervention, monitor existing health risks, and provide valuable reassurance for individuals who are well.

As healthcare professionals often remind their patients, maintaining good health is not only about treating illness—it is equally about preventing disease and identifying concerns before symptoms develop. Annual wellness assessments play a vital role in supporting long-term health, improving outcomes, and promoting a better quality of life.

We sincerely thank Dr. Andrew Odhiambo for once again choosing Dr. Kalebi Labs for his annual health assessment and for setting a positive example of prioritising personal health. His commitment reinforces the message that routine medical check-ups are important for everyone, regardless of age, profession, or current state of health.

At Dr. Kalebi Labs (DKL), we remain committed to providing comprehensive, high-quality diagnostic and wellness services that empower individuals and clinicians to make informed healthcare decisions through accurate, timely, and reliable laboratory medicine.

Your health deserves attention—not only when you’re unwell, but throughout every stage of life. Dr. Andrew Odhiambo

13/07/2026

𝗖𝗵𝗿𝗼𝗺𝗼𝘀𝗼𝗺𝗮𝗹 𝗠𝗶𝗰𝗿𝗼𝗮𝗿𝗿𝗮𝘆 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 (𝗖𝗠𝗔): 𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗶𝗻 𝗣𝗿𝗲𝗻𝗮𝘁𝗮𝗹 𝗮𝗻𝗱 𝗚𝗲𝗻𝗲𝘁𝗶𝗰 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀

As precision medicine continues to transform healthcare, Chromosomal Microarray Analysis (CMA) has become the internationally recommended first-line genetic test for many prenatal and selected postnatal diagnostic evaluations.

Often described as a molecular karyotype, CMA uses high-resolution genome-wide DNA analysis to identify clinically significant chromosomal copy number changes, including microdeletions and microduplications that may not be detected by conventional chromosome analysis (karyotyping). The result is greater diagnostic yield, improved clinical confidence, and faster decision-making for both clinicians and families.

Leading professional bodies, including ACOG, SMFM, and ACMG, recommend CMA in a range of clinical scenarios, particularly for:

🔹 Fetuses with one or more structural abnormalities detected on ultrasound
🔹 Prenatal diagnostic procedures, including chorionic villus sampling (CVS) and amniocentesis
🔹 Investigation of stillbirth, fetal demise, and products of conception (POC)
🔹 Selected postnatal cases involving developmental delay, congenital anomalies, intellectual disability, or unexplained neurodevelopmental disorders

At Dr. Kalebi Labs (DKL), we continue to support clinicians and patients with advanced SNP-based Chromosomal Microarray Analysis (CMA) performed locally, providing high-quality genomic testing backed by expert interpretation and internationally accepted reporting standards.

Our CMA service offers:

✔️ High-resolution genome-wide chromosomal analysis
✔️ Guideline-based interpretation by experienced specialists
✔️ Reliable turnaround times to support timely clinical decisions
✔️ Compatibility with prenatal, postnatal, and POC specimens
✔️ Reduced dependence on overseas referral testing for eligible cases

By delivering advanced genomic diagnostics closer to patients and healthcare providers, DKL is helping improve access to timely, accurate, and clinically actionable genetic information that supports informed pregnancy management.

11/07/2026

𝗦𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹 𝟭-𝗬𝗲𝗮𝗿 𝗦𝘂𝗿𝘃𝗲𝗶𝗹𝗹𝗮𝗻𝗰𝗲 𝗔𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁 𝗯𝘆 𝗞𝗘𝗡𝗔𝗦 – 𝗗𝗿. 𝗞𝗮𝗹𝗲𝗯𝗶 𝗟𝗮𝗯𝘀 𝗖𝗼𝗻𝘁𝗶𝗻𝘂𝗲𝘀 𝘁𝗼 𝗨𝗽𝗵𝗼𝗹𝗱 𝗜𝗦𝗢 𝟭𝟱𝟭𝟴𝟵 𝗘𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲 ✅🌟

Friday 10th July 2026 marks yet another proud milestone for all of us at Dr. Kalebi Labs (DKL) following the successful completion of our 1-Year KENAS ISO 15189 Surveillance Assessment.

After an intensive two-day on-site audit by the Kenya Accreditation Service (KENAS) assessment team, DKL has been recommended for continued ISO 15189 accreditation. This milestone marks our successful transition into the second year of accreditation and reaffirms the strength and maturity of the Quality Management System (QMS) we have built and sustained since our inception.

This achievement builds on our record-breaking initial ISO 15189 accreditation in December 2024, attained just three months after commencing operations. Successfully completing our first annual surveillance assessment demonstrates that quality at DKL is not a one-time achievement or an audit exercise—it is a culture embedded in every process, every specimen, every result, and every patient interaction.

Over the past year, alongside the successful extension of our KENAS-accredited scope, we have continued to expand our specialised diagnostic capabilities while upholding the highest international standards of laboratory practice. Our continued investment in Total Laboratory Automation, Digital Pathology, fully paperless laboratory operations, molecular diagnostics, flow cytometry, immunohistochemistry, microbiology, genetics, DNA paternity testing, and other specialised diagnostic services, complemented by participation in the CAP Proficiency Testing Programme, enables us to deliver increasingly comprehensive, accurate, timely, and clinically meaningful results for patients, healthcare professionals, hospitals, and referring laboratories across Kenya and the region.

We sincerely thank the KENAS assessment team for their professionalism, constructive engagement, and valuable guidance throughout the assessment. Independent assessments such as these play a vital role in driving continual improvement and strengthening confidence in accredited laboratory services.

Heartfelt congratulations to the entire DKL family—our pathologists, laboratory scientists, quality and compliance professionals, technical services, client services, logistics, IT, administration, finance, and support teams. This achievement belongs to every colleague whose dedication, teamwork, professionalism, and relentless pursuit of excellence continue to demonstrate that a homegrown Kenyan laboratory can operate at the highest international standards while embracing innovation.

As we embark on our second year as an ISO 15189 accredited laboratory, our commitment remains unwavering: continuous improvement, clinical excellence, innovation, and uncompromising quality.

We look forward to further expanding our specialised test menu, improving turnaround times, strengthening digital connectivity, and delivering even greater value to patients and healthcare providers under our New Era of Lab Services.

Congratulations once again to the outstanding DKL team. The journey towards even greater excellence continues.

10/07/2026

𝗞𝗡𝗛 𝗮𝗻𝗱 𝗗𝗞𝗟 𝗔𝗱𝘃𝗮𝗻𝗰𝗲 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝘁𝗼 𝗘𝘅𝗽𝗮𝗻𝗱 𝗔𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝗦𝗽𝗲𝗰𝗶𝗮𝗹𝗶𝘀𝗲𝗱 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝘆 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀

As part of our ongoing commitment to strengthening collaboration with Kenya's premier national referral hospital, Dr. Ahmed Kalebi, Founder, Executive Chairman & CEO of Dr. Kalebi Labs (DKL), yesterday participated in a strategic review meeting convened by the Chief Executive Officer of Kenyatta National Hospital (KNH), Dr. Richard Lesiyampe, CBS, to review the progress of the KNH/T/59/2025–2027 Framework Contract for Provision of Referral Clinical Laboratory Test Services as it enters its second year.

The discussions focused on strengthening the structured specimen referral system to ensure patients requiring specialised and high-complexity laboratory investigations continue to access these services seamlessly within the KNH care pathway while supporting clinicians with timely, reliable diagnostic information.

The teams reviewed progress in optimising the referral pathway—from patient registration and billing at KNH, secure specimen referral, logistics and cold-chain management, specialised testing at DKL, and prompt return of results. They also explored opportunities to further enhance digital integration, operational coordination, governance, quality systems and turnaround times.

The meeting was attended by Dr. Richard Lesiyampe, CBS; Dr. Ahmed Kalebi; Dr. Francis Ndiangui; Dr. Rabia Mukadam; senior laboratory professionals from KNH; and members of the laboratory, operations and client relations teams from both institutions.

Since the framework contract commenced in August 2025, the partnership has enabled hundreds of KNH patients every week to benefit from specialised referral laboratory investigations. By complementing KNH's in-house laboratory services with specialised and backup testing, the collaboration continues to expand local access to advanced diagnostics, supporting earlier diagnosis, informed clinical decision-making and improved patient outcomes.

09/07/2026

𝗙𝘂𝗹𝗹 𝗞𝗥𝗔 𝗲𝗧𝗜𝗠𝗦 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 & 𝗥𝗲𝗮𝗹-𝗧𝗶𝗺𝗲 𝗘-𝗜𝗻𝘃𝗼𝗶𝗰𝗶𝗻𝗴 𝗮𝘁 𝗗𝗞𝗟

Dr. Kalebi Labs (DKL) is pleased to inform our valued clients and partners that our billing system is fully compliant with the Tax Procedures (Electronic Tax Invoice) Regulations, 2024 (Legal Notice No. 64).

In Kenya’s evolving tax landscape, compliance is not merely a regulatory requirement—it is central to transparent, accountable, and ethical business practice. The Kenya Revenue Authority (KRA) eTIMS platform enables real-time invoicing, strengthens tax compliance, and protects both businesses and the public from non-compliant practices. At DKL, this is seamlessly embedded into our operations as part of our commitment to integrity and operational excellence.

Our Laboratory Information System (LIS) has been fully integrated with the KRA eTIMS platform for over a year, enabling seamless, real-time electronic invoicing in full alignment with regulatory requirements.

𝙒𝙝𝙖𝙩 𝙏𝙝𝙞𝙨 𝙈𝙚𝙖𝙣𝙨 𝙛𝙤𝙧 𝙔𝙤𝙪:

✔️ Automated electronic invoicing for every transaction
✔️ Real-time transmission of invoices to KRA
✔️ Full compliance with statutory invoice requirements, including QR codes and tax details

𝙄𝙢𝙥𝙤𝙧𝙩𝙖𝙣𝙩 𝙍𝙚𝙜𝙪𝙡𝙖𝙩𝙤𝙧𝙮 𝙍𝙚𝙦𝙪𝙞𝙧𝙚𝙢𝙚𝙣𝙩:

Each patient laboratory service must be processed as an individual transaction and issued with a separate eTIMS invoice, as mandated under the Regulations. Monthly statements cannot substitute statutory eTIMS invoices.

𝘾𝙡𝙞𝙚𝙣𝙩 𝘼𝙘𝙘𝙚𝙨𝙨 & 𝘾𝙤𝙣𝙫𝙚𝙣𝙞𝙚𝙣𝙘𝙚:

Corporate clients can securely access patient eTIMS invoices via the DKL Client Portal 🌐 http://My.DKL.co.ke.

Monthly statements and billing summaries are provided separately to support reconciliation and internal reporting.

𝙊𝙪𝙧 𝘾𝙤𝙢𝙢𝙞𝙩𝙢𝙚𝙣𝙩:

This integration ensures:
• Full regulatory compliance
• Enhanced billing transparency
• Efficient, accessible invoicing services

For any assistance regarding eTIMS invoices or statements, our Client Services team is available to support you.

Thank you for your continued trust in Dr. Kalebi Labs (DKL).

09/07/2026

𝗞𝗻𝗼𝘄 𝗬𝗼𝘂𝗿 𝗧𝗲𝘀𝘁 𝗣𝗿𝗶𝗰𝗲 𝗕𝗲𝗳𝗼𝗿𝗲 𝗬𝗼𝘂 𝗩𝗶𝘀𝗶𝘁 — 𝗙𝘂𝗹𝗹𝘆 𝗧𝗿𝗮𝗻𝘀𝗽𝗮𝗿𝗲𝗻𝘁, 𝗡𝗼 𝗦𝘂𝗿𝗽𝗿𝗶𝘀𝗲𝘀.

At Dr. Kalebi Labs (DKL), we believe that accessing quality diagnostic services should be simple, transparent, and convenient.

Our Customer Portal and DKL App allow you to search for laboratory tests, view accurate pricing instantly, and estimate the total cost before placing an order or visiting the laboratory. There are no hidden charges—just clear, competitive pricing you can trust.

Whether you are a patient, clinician, or healthcare facility, you can:

✔ Search for thousands of laboratory tests by name or keyword.
✔ View transparent prices instantly.
✔ Order tests online at your convenience.
✔ Request home, office, or bedside sample collection.
✔ Access one of Kenya’s most comprehensive in-house diagnostic test menus.
✔ Receive fast, reliable results supported by our advanced laboratory technologies.

At DKL, we’re committed to making quality diagnostics more accessible through innovation, convenience, and transparency.

Quality Diagnostics. Transparent Pricing. Trusted Results.

📍 Dr. Kalebi Labs
Real Towers Annexe, Hospital Road, Upper Hill, Nairobi

🌐 www.dkl.co.ke
📱 Download the DKL App on Android and iOS
📞 +254 750 333 000 | +254 111 057 333 / 4 / 5

07/07/2026

𝗢𝗽𝗲𝗻 𝟮𝟰/𝟳 — 𝗔𝗹𝘄𝗮𝘆𝘀 𝗛𝗲𝗿𝗲 𝗪𝗵𝗲𝗻 𝗬𝗼𝘂 𝗡𝗲𝗲𝗱 𝗨𝘀

Healthcare never sleeps—and neither do we.

At Dr. Kalebi Labs (DKL), we are open 24 hours a day, 7 days a week, including weekends and public holidays, ensuring uninterrupted access to world-class laboratory and diagnostic services whenever they are needed.

Whether you are:
✅ Walking in for routine or specialised laboratory testing,
✅ Requesting a home, office, or bedside sample collection,
✅ A doctor or healthcare facility submitting urgent or referred patient samples,
✅ A hospital requiring emergency laboratory support, or
✅ One of our Designated Service Partners (DSPs), Roaming Phlebotomy Partners (RPPs), or courier partners delivering specimens,

our dedicated team is always on hand to receive, process, analyse, and report results with speed, accuracy, and professionalism.

From our ultramodern National and International Referral Laboratory in Upper Hill, Nairobi, we provide one of Kenya’s most comprehensive in-house test menus, rapid turnaround times, advanced diagnostic technologies, and seamless digital access to results through the DKL App and Customer Portal.

Because illness does not keep office hours, neither do we.

Dr. Kalebi Labs (DKL) — Trusted Diagnostics, Anytime.

📍 Real Towers Annexe, Hospital Road, Upper Hill, Nairobi
📞 +254 750 333 000 | +254 111 057 333 / 4 / 5
🌐 www.dkl.co.ke

07/07/2026

𝗖𝘆𝘀𝘁𝗮𝘁𝗶𝗻 𝗖 𝗲𝗚𝗙𝗥: 𝗧𝗵𝗲 𝗡𝗲𝘅𝘁 𝗦𝘁𝗮𝗻𝗱𝗮𝗿𝗱 𝗶𝗻 𝗞𝗶𝗱𝗻𝗲𝘆 𝗛𝗲𝗮𝗹𝘁𝗵 𝗔𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁

For decades, kidney function has been assessed using creatinine-based eGFR — but creatinine is influenced by age, s*x, diet, muscle mass, and even ethnicity, which can lead to inaccurate results and missed cases of CKD.

𝙏𝙝𝙖𝙩’𝙨 𝙬𝙝𝙚𝙧𝙚 𝘾𝙮𝙨𝙩𝙖𝙩𝙞𝙣 𝘾 𝙘𝙤𝙢𝙚𝙨 𝙞𝙣.
This innovative biomarker is produced consistently by every cell in the body and is not affected by the limitations of creatinine, making it a far more accurate and reliable test.

💡 𝙃𝙚𝙧𝙚’𝙨 𝙬𝙝𝙮 𝘾𝙮𝙨𝙩𝙖𝙩𝙞𝙣 𝘾 𝙞𝙨 𝙙𝙞𝙛𝙛𝙚𝙧𝙚𝙣𝙩:
✔ Detects kidney disease earlier and more accurately
✔ Reduces risk of underdiagnosis in elderly or low-muscle patients
✔ Improves 𝙙𝙧𝙪𝙜 𝙨𝙖𝙛𝙚𝙩𝙮 by preventing creatinine-driven overestimation
✔ Provides 𝙗𝙚𝙩𝙩𝙚𝙧 𝙧𝙞𝙨𝙠 𝙥𝙧𝙚𝙙𝙞𝙘𝙩𝙞𝙤𝙣 for CKD progression, heart disease, and mortality
✔ Ensures equitable care across diverse populations

Global kidney experts (KDIGO, NKF, ASN) now recommend Cystatin C testing to confirm CKD and improve eGFR accuracy. The conversation has shifted, 𝙞𝙩’𝙨 𝙣𝙤 𝙡𝙤𝙣𝙜𝙚𝙧 𝙞𝙛 𝙬𝙚 𝙨𝙝𝙤𝙪𝙡𝙙 𝙪𝙨𝙚 𝘾𝙮𝙨𝙩𝙖𝙩𝙞𝙣 𝘾, 𝙗𝙪𝙩 𝙬𝙝𝙚𝙣 𝙖𝙣𝙙 𝙝𝙤𝙬 𝙤𝙛𝙩𝙚𝙣.

📍 𝐍𝐨𝐰 𝐚𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐚𝐭 𝐃𝐫. 𝐊𝐚𝐥𝐞𝐛𝐢 𝐋𝐚𝐛𝐬 (𝐃𝐊𝐋) with transparent pricing and rapid turnaround.
📞 Call: 0111 057 333 / 4 / 5
📱 WhatsApp: 0750 333 000 / 0769 333 000
🌐 http://dkl.co.ke/labtests

05/07/2026

𝗗𝗞𝗟 𝗪𝗲𝗹𝗰𝗼𝗺𝗲𝘀 𝗦𝗵𝗲𝗶𝗸𝗵 𝗥𝗮𝘀𝗵𝗶𝗱 𝗔𝗯𝘂 𝗡𝗮𝗷𝗺𝗮 𝗳𝗼𝗿 𝗮 𝗩𝗶𝘀𝗶𝘁 𝘁𝗼 𝗢𝘂𝗿 𝗨𝗹𝘁𝗿𝗮𝗺𝗼𝗱𝗲𝗿𝗻 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝘆

Last Friday, following his inspiring Jumu'ah lecture at Masjid Salama in Kibra, Dr. Kalebi Labs (DKL) had the honour of hosting the renowned Islamic scholar, educator, and media personality, Sheikh Rashid Abu Najma, at our National and International Referral Laboratory in Upper Hill, Nairobi.

Sheikh Rashid Abu Najma is an alumnus of the Islamic University of Africa in Sudan and served with distinction as the first Muslim Chaplain at Kenyatta National Hospital (KNH), where he dedicated three years to providing spiritual care and guidance. He is currently widely recognized as the host of the popular children's television program "Abu Najma With Kids" on Jamia TV.

During his visit, Sheikh Rashid was taken on a comprehensive tour of DKL's state-of-the-art, fully automated, and paperless laboratory facilities, where he had the opportunity to experience firsthand the advanced diagnostic technologies and systems that underpin our commitment to delivering world-class healthcare services. He also underwent laboratory testing during his visit.

We are deeply honoured by Sheikh Rashid's visit and appreciate the opportunity to showcase how innovation, technology, and excellence are transforming diagnostic medicine in Kenya and across Africa.

05/07/2026

𝗘𝘅𝗽𝗮𝗻𝗱𝗶𝗻𝗴 𝗔𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝗪𝗼𝗿𝗹𝗱-𝗖𝗹𝗮𝘀𝘀 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗧𝗵𝗿𝗼𝘂𝗴𝗵 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽𝘀

Dr. Kalebi Labs (DKL) is proud to work alongside a growing network of leading insurance providers, corporates, healthcare organizations, and institutions to make high-quality diagnostic services more accessible to individuals and communities across Kenya.

Through these partnerships, members and beneficiaries enjoy access to 𝘄𝗼𝗿𝗹𝗱-𝗰𝗹𝗮𝘀𝘀, 𝗜𝗦𝗢 𝟭𝟱𝟭𝟴𝟵:𝟮𝟬𝟮𝟮-𝗮𝗰𝗰𝗿𝗲𝗱𝗶𝘁𝗲𝗱 laboratory services delivered with precision, reliability, efficiency, and patient-centered care.

At DKL, we offer one of the most comprehensive diagnostic test menus in the region, supported by advanced laboratory technologies, highly skilled professionals, and robust quality systems that ensure accurate and dependable results for informed clinical decision-making.

Our commitment extends beyond quality to value—offering 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲, 𝘁𝗿𝗮𝗻𝘀𝗽𝗮𝗿𝗲𝗻𝘁, and 𝗰𝗼𝘀𝘁-𝗲𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲 pricing while maintaining the highest standards of diagnostic excellence.

📍 Access DKL services 24/7 at our ultramodern National and International Referral Laboratory at Real Towers Annexe, Upper Hill, Nairobi, conveniently located next to Kenyatta National Hospital (KNH), as well as through our expanding nationwide network of Designated Service Partners (DSPs).

𝗧𝗿𝘂𝘀𝘁𝗲𝗱 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀. 𝗧𝗿𝗮𝗻𝘀𝗽𝗮𝗿𝗲𝗻𝘁 𝗣𝗿𝗶𝗰𝗶𝗻𝗴. 𝗡𝗮𝘁𝗶𝗼𝗻𝘄𝗶𝗱𝗲 𝗥𝗲𝗮𝗰𝗵.

Explore our full test menu and transparent pricing:
[dkl.co.ke/labtests](dkl.co.ke/labtests)

DKL Dr.Kalebi Labs

14/07/2026

13/07/2026

11/07/2026

10/07/2026

09/07/2026

09/07/2026

07/07/2026

07/07/2026

05/07/2026

05/07/2026

Address

Website

Alerts

Shortcuts

Share

Category

Listing takedown request